tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AZN Stock Latest News

AstraZeneca’s CAMBRIA-1 Study: A New Hope in Breast Cancer Treatment?
Company AnnouncementsAstraZeneca’s CAMBRIA-1 Study: A New Hope in Breast Cancer Treatment?
22h ago
AZN
AstraZeneca’s Phase III Study on Advanced Liver Cancer: Key Updates for Investors
PremiumCompany Announcements
AstraZeneca’s Phase III Study on Advanced Liver Cancer: Key Updates for Investors
22h ago
AZN
AstraZeneca’s Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
AstraZeneca’s Prostate Cancer Study: A Potential Game-Changer?
22h ago
AZN
AstraZeneca’s New Study on AZD4360: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s New Study on AZD4360: A Potential Game-Changer in Cancer Treatment
22h ago
AZN
AstraZeneca’s Innovative Approach to Colorectal Cancer: A New Phase II Study
PremiumCompany Announcements
AstraZeneca’s Innovative Approach to Colorectal Cancer: A New Phase II Study
22h ago
AZN
PRXL
AstraZeneca’s Phase III Study on AZD0901: A Potential Game Changer in Gastric Cancer Treatment
PremiumCompany AnnouncementsAstraZeneca’s Phase III Study on AZD0901: A Potential Game Changer in Gastric Cancer Treatment
22h ago
AZN
AstraZeneca’s Phase III Study on NSCLC: A Potential Game-Changer
Premium
Company Announcements
AstraZeneca’s Phase III Study on NSCLC: A Potential Game-Changer
22h ago
AZN
PRXL
AstraZeneca’s TITANium Study: A New Hope for B-Cell Malignancies
Premium
Company Announcements
AstraZeneca’s TITANium Study: A New Hope for B-Cell Malignancies
22h ago
AZN
AstraZeneca’s Phase III Study on Baxdrostat and Dapagliflozin: A Potential Game-Changer for CKD and Hypertension
PremiumCompany Announcements
AstraZeneca’s Phase III Study on Baxdrostat and Dapagliflozin: A Potential Game-Changer for CKD and Hypertension
22h ago
AZN
AstraZeneca’s Phase III Study on NSCLC Treatment: A Potential Game-Changer?
PremiumCompany Announcements
AstraZeneca’s Phase III Study on NSCLC Treatment: A Potential Game-Changer?
22h ago
AZN
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors
22h ago
AZN
AstraZeneca reports Imfinzi approved in EU for MIBC
PremiumThe Fly
AstraZeneca reports Imfinzi approved in EU for MIBC
1d ago
AZN
Summit Therapeutics Stock (SMMT) Jumps 8% on Talks of $15B Licensing Deal with AstraZeneca
PremiumMarket NewsSummit Therapeutics Stock (SMMT) Jumps 8% on Talks of $15B Licensing Deal with AstraZeneca
1d ago
AZN
SMMT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2d ago
AZN
RVMD
AstraZeneca’s Anifrolumab Study: A Potential Game-Changer for Inflammatory Myopathies
Premium
Company Announcements
AstraZeneca’s Anifrolumab Study: A Potential Game-Changer for Inflammatory Myopathies
2d ago
AZN
AstraZeneca’s New Study on Asthma Biologics in China: Market Insights
PremiumCompany Announcements
AstraZeneca’s New Study on Asthma Biologics in China: Market Insights
2d ago
AZN
AstraZeneca’s Phase I Study on AZD5004: A Potential Market Game-Changer?
PremiumCompany Announcements
AstraZeneca’s Phase I Study on AZD5004: A Potential Market Game-Changer?
2d ago
AZN
AstraZeneca’s Tozorakimab Study: A Promising Update for Investors
PremiumCompany Announcements
AstraZeneca’s Tozorakimab Study: A Promising Update for Investors
2d ago
AZN
AstraZeneca’s Promising Phase 3 Study on Acalabrutinib and R-CHOP for Untreated DLBCL
PremiumCompany Announcements
AstraZeneca’s Promising Phase 3 Study on Acalabrutinib and R-CHOP for Untreated DLBCL
2d ago
AZN
AstraZeneca’s Tezepelumab Study: Real-World Impact on Asthma and Cough
PremiumCompany AnnouncementsAstraZeneca’s Tezepelumab Study: Real-World Impact on Asthma and Cough
2d ago
AZN
AstraZeneca’s Real-world Study on Trastuzumab Deruxtecan: Implications for Investors
Premium
Company Announcements
AstraZeneca’s Real-world Study on Trastuzumab Deruxtecan: Implications for Investors
2d ago
AZN
AstraZeneca’s Real-World Study on Tezepelumab for Severe Asthma: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Real-World Study on Tezepelumab for Severe Asthma: Key Insights for Investors
2d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >